Michał Kasperczak

13PUBLICATIONS
11CO-AUTHORS
Molecular targetsPredictive and prognostic markersNephrology and urologyCancer diagnosisEcohydrology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 12, 2026
From Genes to Proteins: The Indispensable Role of Proteogenomics in Advancing Clear Cell Renal Cell Carcinoma Research.

|Jul 12, 2025
PROM1 and EFTUD2 Expression in High-Grade Clear Cell Renal Cell Carcinoma as a Molecular Marker for Survival Rate.

Michał Kasperczak, Iga Kołodziejczak-Guglas, Filip Kasperczak

|Jul 12, 2025
Immunohistological Examination of HEATR1 and SLC27A2 Expression in ccRCC Samples to Evaluate Their Potential as Prognostic Markers-A Preliminary Study.

Michał Kasperczak, Iga Kołodziejczak-Guglas, Karolina Pawłowska-Kasperczak

|May 14, 2025
Prognostic Significance of Overexpression of BCL9 and TPX2 in High-Grade Clear Cell Renal Cell Carcinoma: Prognostic Markers for Metastasis and Survival.

Michał Kasperczak, Iga Kołodziejczak-Guglas, Filip Kasperczak

|May 01, 2025
Renal Trauma: A 4-Year Retrospective Review of Injury Severity, Treatment Approaches, and Outcomes from a Polish Trauma Center.

Michał Kasperczak, Anita Zaręba, Karolina Pawłowska-Kasperczak

|Aug 29, 2024
Prognostic Significance of Elevated UCHL1, SNRNP200, and PAK4 Expression in High-Grade Clear Cell Renal Cell Carcinoma: Insights from LC-MS/MS Analysis and Immunohistochemical Validation.

Michał Kasperczak, Gabriel Bromiński, Iga Kołodziejczak-Guglas

Pageof 3

Frequent Collaborators

6 joint publications

Jadwiga Kuciel-Lewandowska

1 joint publications

Bożena Bogut

1 joint publications

Roman Heider

1 joint publications

Wojciech T Laber